Category: Finance
What’s in store for 2024: Greenvale Energy
Stockhead’s Ashtyn Hiron sits down with Greenvale Energy (ASX:GRV) CEO Mark Turner to close the books on 2023 and gain a sneak peek into what’s around [more…]
Zenith Minerals regains full control of two highly prospective WA lithium projects
A failed earn-in deal has returned two WA lithium projects back into Zenith’s 100% control Split Rocks is immediately north of SQM and Wesfarmers’ Mt [more…]
NickelX to spin off European IP for a stake in upcoming ASX debutante Eyre Metals
Drilling imminent at Dalwallinu critical minerals project NickelX to receive 1 million shares in Eyre Metals subject to ASX listing Eyre listing planned for this [more…]
What’s in store for 2024: Maronan Metals
Stockhead’s Sarah Hughan sits down with Maronan Metals (ASX:MMA) managing director Richard Carlton to close the books on 2023 and gain a sneak peek into what’s [more…]
‘Bitcoin is unstoppable’, ‘the floodgates are open’ – bullish sentiment abounds post ETF approvals
Now that SEC chief Gary “You Win This Round” Gensler has rubber stamped 11 spot Bitcoin ETFs on a momentously historic day for magic internet [more…]
What’s in store for 2024: Challenger Gold
Stockhead’s Ashtyn Hiron sits down with Challenger Gold (ASX:CEL) CEO and managing director Kris Knauer to close the books on 2023 and gain a sneak [more…]
Resources Top 5: Kali’s lithium neighbour feels nearology glow, Aspire’s product makes the phattest coke
Coal from AKM’s 281Mt Ovoot project in Mongolia designated super high quality Maximus has multiple lithium soil anomalies at Lefroy project, next door to red [more…]
ASX Small Caps Lunch Wrap: Whose not-so-strategic sock put them in prison this week?
Local markets are higher, but one feels not heaps happier on Thursday in Sydney. It could be a general sense of apathy, or it could [more…]
ASX Health Stocks: Lumos, Singular, and Imricor all jump today after deals and approvals
Lumos Diagnostics surges after deal with Nasdaq-listed Hologic Singular Health’s shares also jump after deal with US Veterans Imricor has obtained approval from Saudi’s drugs [more…]
What’s in store for 2024: Zeotech
Stockhead’s Ashtyn Hiron sits down with Zeotech (ASX:ZEO) CEO Scott Burkhart to close the books on 2023 and gain a sneak peek into what’s around [more…]